Saturday, March 5, 2022

Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection

| InvestorPlace     •     March 4, 2022, 4:12 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin. The post…
| InvestorPlace     •     March 4, 2022, 4:15 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should…

No comments:

Post a Comment

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks | InvestorPlace     •     July 21...